Cover Image
Market Research Report
Product code 
757037

Europe Opioids Drugs Market Forecast 2019-2028

Published: | Inkwood Research | 124 Pages | Delivery time: 2-3 business days

Price

Back to Top
Europe Opioids Drugs Market Forecast 2019-2028
Published: May 11, 2020
Inkwood Research
Content info: 124 Pages
Delivery time: 2-3 business days
  • ALL
  • Description
  • Table of Contents
Description

KEY FINDINGS

The Europe opioids drugs market is predicted to record a CAGR of 2.45% over the estimated period of 2019-2028. The growing geriatric population demanding effective pain therapeutics is one of the crucial factors contributing to the growth of the market in the region.

MARKET FINDINGS

The Europe opioids drugs market is segmented into countries like France, Poland, Germany, the UK, Belgium, Russia, Italy, and the rest of Europe for further survey. In Russia, the reason for opioid underuse is because of physician concerns about potential opioid dependence in their patients and diversion into illicit use. An educational program for primary care physicians concerning the current principles of opioid treatment of chronic cancer and non-cancer pain was initiated in St. Petersburg. Russia may have a shortage of certain pain management drugs this year due to the end of supplies, for their production from the UK is affected due to the COVID-19. In Belgium, the number of people taking addictive pain killers has increased by 56% in ten years. The current public health crisis due to the COVID-19 pandemic raises serious concern for people who use drugs.

In Poland, legislation was adopted on 31 January,1985 to tackle the increasing drug abuse, and the act provides effective and preventive treatment measures, as well as a severe punishment for illicit drug trafficking. The spread of the COVID-19 pandemic is making it difficult for people suffering from chronic pain to access treatment, as most of the outpatient services are strictly regulated. The physicians are finding alternate ways, such as video conferencing, to treat these patients. In Spain, the increasing substitution treatments to reduce the overuse of opioids are driving the market.

COMPETITIVE INSIGHTS

Some of the leading companies registering their presence in the market are Janssen Pharmaceuticals, Inc. Hikma Pharmaceuticals, Sanofi SA, Allergan plc, Pfizer Inc, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Table of Contents
Product Code: 22727

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. MARKET DEFINITION
  • 3.2. KEY DRIVERS
    • 3.2.1. INCREASING ROAD ACCIDENTS AND SURGICAL PROCEDURES
    • 3.2.2. ESCALATING PALLIATIVE CARE FOR PATIENTS SUFFERING INTENSELY
    • 3.2.3. USAGE OF ABUSE DETERRENT FORMULATIONS TO RESTRICT THE OPIOID ABUSE
    • 3.2.4. GROWING OCCURRENCE OF CHRONIC PAIN
  • 3.3. KEY RESTRAINTS
    • 3.3.1. MISUSE OF OPIOIDS
    • 3.3.2. STRINGENT REGULATORY FRAMEWORK

4. KEY ANALYTICS

  • 4.1. KEY INVESTMENT INSIGHTS
  • 4.2. PORTER'S FIVE FORCE ANALYSIS
    • 4.2.1. BUYER POWER
    • 4.2.2. SUPPLIER POWER
    • 4.2.3. SUBSTITUTION
    • 4.2.4. NEW ENTRANTS
    • 4.2.5. INDUSTRY RIVALRY
  • 4.3. OPPORTUNITY MATRIX
  • 4.4. VENDOR LANDSCAPE
  • 4.5. REGULATORY FRAMEWORK
  • 4.6. TECHNOLOGICAL ADVANCEMENT

5. MARKET BY PRODUCT

  • 5.1. BUPRENORPHINE
  • 5.2. FENTANYL
  • 5.3. HYDROCODONE
  • 5.4. MORPHINE
  • 5.5. OXYCODONE
  • 5.6. TRAMADOL
  • 5.7. OTHER PRODUCTS

6. MARKET BY APPLICATION

  • 6.1. PAIN RELIEF
    • 6.1.1. CANCER PAIN
    • 6.1.2. POSTOPERATIVE PAIN MANAGEMENT
    • 6.1.3. LOW BACK PAIN
    • 6.1.4. ORTHOPEDIC
    • 6.1.5. FIBROMYALGIA
    • 6.1.6. NEUROPATHIC
  • 6.2. ANESTHESIA
  • 6.3. COUGH SUPPRESSION
  • 6.4. DIARRHEA SUPPRESSION
  • 6.5. DEADDICTION

7. GEOGRAPHICAL ANALYSIS

  • 7.1. EUROPE
    • 7.1.1. THE UNITED KINGDOM
    • 7.1.2. GERMANY
    • 7.1.3. FRANCE
    • 7.1.4. ITALY
    • 7.1.5. RUSSIA
    • 7.1.6. BELGIUM
    • 7.1.7. POLAND
    • 7.1.8. REST OF EUROPE

8. COMPANY PROFILES

  • 8.1. ACURA PHARMACEUTICALS INC
  • 8.2. ALLERGAN PLC
  • 8.3. BIODELIVERY SCIENCES INTERNATIONAL INC
  • 8.4. CIPHER PHARMACEUTICALS INC
  • 8.5. COLLEGIUM PHARMACEUTICAL INC
  • 8.6. DAIICHI SANKYO INC
  • 8.7. EGALET CORP
  • 8.8. HIKMA PHARMACEUTICALS PLC
  • 8.9. INDIVIOR INC
  • 8.10. JANSSEN PHARMACEUTICALS INC
  • 8.11. JOHNSON & JOHNSON
  • 8.12. LANNETT CO. INC
  • 8.13. LUPIN LTD
  • 8.14. MYLAN NV
  • 8.15. PFIZER INC
  • 8.16. PURDUE PHARMA LP
  • 8.17. SANOFI-AVENTIS S.A
  • 8.18. SUN PHARMACEUTICAL INDUSTRIES LIMITED (SUN PHARMA)
  • 8.19. TEVA PHARMACEUTICAL INDUSTRIES LTD

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - OPIOIDS DRUGS
  • TABLE 2: EUROPE OPIOIDS DRUGS MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 3: EUROPE OPIOIDS DRUGS MARKET, BY PRODUCT, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 4: EUROPE OPIOIDS DRUGS MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 5: EUROPE OPIOIDS DRUGS MARKET, BY APPLICATION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 6: EUROPE PAIN RELIEF MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION):
  • TABLE 7: EUROPE PAIN RELIEF MARKET, BY TYPE, FORECAST YEARS, 2019-2028 (IN $ MILLION):
  • TABLE 8: EUROPE OPIOIDS DRUGS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 9: EUROPE OPIOIDS DRUGS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)

LIST OF FIGURES

  • FIGURE 1: KEY INVESTMENT INSIGHTS
  • FIGURE 2: PORTER'S FIVE FORCE ANALYSIS
  • FIGURE 3: OPPORTUNITY MATRIX
  • FIGURE 4: VENDOR LANDSCAPE
  • FIGURE 5: EUROPE OPIOIDS DRUGS MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2019
  • FIGURE 6: EUROPE OPIOIDS DRUGS MARKET, BY BUPRENORPHINE, 2019-2028 (IN $ MILLION)
  • FIGURE 7: EUROPE OPIOIDS DRUGS MARKET, BY FENTANYL, 2019-2028 (IN $ MILLION)
  • FIGURE 8: EUROPE OPIOIDS DRUGS MARKET, BY HYDROCODONE, 2019-2028 (IN $ MILLION)
  • FIGURE 9: EUROPE OPIOIDS DRUGS MARKET, BY MORPHINE, 2019-2028 (IN $ MILLION)
  • FIGURE 10: EUROPE OPIOIDS DRUGS MARKET, BY OXYCODONE, 2019-2028 (IN $ MILLION)
  • FIGURE 11: EUROPE OPIOIDS DRUGS MARKET, BY TRAMADOL, 2019-2028 (IN $ MILLION)
  • FIGURE 12: EUROPE OPIOIDS DRUGS MARKET, BY OTHER PRODUCTS, 2019-2028 (IN $ MILLION)
  • FIGURE 13: EUROPE OPIOIDS DRUGS MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2019
  • FIGURE 14: EUROPE OPIOIDS DRUGS MARKET, BY PAIN RELIEF, 2019-2028 (IN $ MILLION)
  • FIGURE 15: EUROPE PAIN RELIEF MARKET, BY CANCER PAIN, 2019-2028 (IN $ MILLION)
  • FIGURE 16: EUROPE PAIN RELIEF MARKET, BY POSTOPERATIVE PAIN MANAGEMENT, 2019-2028 (IN $ MILLION)
  • FIGURE 17: EUROPE PAIN RELIEF MARKET, BY LOW BACK PAIN, 2019-2028 (IN $ MILLION)
  • FIGURE 18: EUROPE PAIN RELIEF MARKET, BY ORTHOPEDIC, 2019-2028 (IN $ MILLION)
  • FIGURE 19: EUROPE PAIN RELIEF MARKET, BY FIBROMYALGIA, 2019-2028 (IN $ MILLION)
  • FIGURE 20: EUROPE PAIN RELIEF MARKET, BY NEUROPATHIC, 2019-2028 (IN $ MILLION)
  • FIGURE 21: EUROPE OPIOIDS DRUGS MARKET, BY ANESTHESIA, 2019-2028 (IN $ MILLION)
  • FIGURE 22: EUROPE OPIOIDS DRUGS MARKET, BY COUGH SUPPRESSION, 2019-2028 (IN $ MILLION)
  • FIGURE 23: EUROPE OPIOIDS DRUGS MARKET, BY DIARRHEA SUPPRESSION, 2019-2028 (IN $ MILLION)
  • FIGURE 24: EUROPE OPIOIDS DRUGS MARKET, BY DEADDICTION, 2019-2028 (IN $ MILLION)
  • FIGURE 25: EUROPE OPIOIDS DRUGS MARKET, COUNTRY OUTLOOK, 2018 & 2028 (IN %)
  • FIGURE 26: THE UNITED KINGDOM OPIOIDS DRUGS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 27: GERMANY OPIOIDS DRUGS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 28: FRANCE OPIOIDS DRUGS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 29: ITALY OPIOIDS DRUGS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 30: RUSSIA OPIOIDS DRUGS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 31: BELGIUM OPIOIDS DRUGS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 32: POLAND OPIOIDS DRUGS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 33: REST OF EUROPE OPIOIDS DRUGS MARKET, 2019-2028 (IN $ MILLION)